Spotlight on cancer immunotherapies

Novel mechanisms regulate immune response to cancer and infection

Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.

Spotlight on cancer immunotherapies

Advances in cancer immunotherapy have shown promising results for treatment of tumors, yet challenges related to therapeutic efficacy and manufacturing processes need to be overcome.

Dr Zeidan on the Evaluation of Immunotherapy and Other Novel Therapies in MDS

Amer Zeidan, MBBS, discusses completed and ongoing research evaluating immunotherapy and other novel agents in patients with myelodysplastic syndromes.

According to the results of cancer immunotherapy trials presented at the latest meeting of the American Association for Cancer Research, it was announced that it has yielded successful results in many types of cancer without surgery. In this method, immune cells are strengthened and directly fight tumors thanks to checkpoint inhibitors. 92 percent of the patients who participated in the study had no symptoms of cancer after two years. It was see…

What if the body could learn to defend itself (or almost) against certain cancers? It is the principle of immunotherapy: stimulate immune defenses to target and eliminate tumour cells.

Researchers find genetic fingerprints to predict efficacy of...

Last Updated on May 8, 2025 by Team THIP Jerusalem, May 8 (IANS) Israeli researchers have identified a genetic “fingerprint” that helps predict the effectiveness of immunotherapy treatments, according to a study. The study, by the Israel Institute of Technology (Technion), stated that the discovery would help improve the personalisation of immunotherapy treatments, Xinhua news […] The post Researchers find genetic fingerprints to predict efficac…